Table:
begin	end	state
1	26	cytoplasmic
27	57	transmembrane
58	65	non-cytoplasmic
66	88	transmembrane
89	98	cytoplasmic
99	119	transmembrane
120	125	non-cytoplasmic
126	152	transmembrane
153	163	cytoplasmic
164	187	transmembrane
188	198	non-cytoplasmic
199	220	transmembrane
221	252	cytoplasmic
253	277	transmembrane
278	288	non-cytoplasmic
289	310	transmembrane
311	317	cytoplasmic
318	338	transmembrane
339	344	non-cytoplasmic
345	369	transmembrane
370	380	cytoplasmic
381	399	transmembrane
400	410	non-cytoplasmic
411	429	transmembrane
430	436	cytoplasmic

Input:
>SMc01869
MTDATTSLSPQDGALHRQAVNSPARVLFASLVGTTIEFFDFYVYATAAVIIFPHLFFPAA
DPTSAMLQSLATFSIAFFARPLGAVIFGHFGDRIGRKATLVAALMTMGISTVVIGLLPTY
STIGVVAPLLLALCRFGQGLGLGGEWGGAVLLATENAPEGKRSWYAMFPQLGAPIGFILS
AGTFLILGEVMSEEAFLAWGWRVPFIASVLLVIVGLYVRLKITETPEFQKAIDKHERVEV
PVAAIFRSHKRSLVLGTFVALATFVLFYLMTVFSLSWGTTKLGYSREQFLLVQMTGVVFF
GLMIPVSGILSDRFGRRLVLVLTTIGIGVFGLFMAPLLSSGLGGAFVFSIVGLGLMGLTY
GPIGAALAAPFPTAVRYTGASMTFNLAGIFGASLAPYIATWLATNYSLGHVGYYLLAAAS
ITLVCLLLSNEEEVSG

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server